C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
ROMJF Equity

Rubicon Organics

OTCMKTS · ROMJF

$0.36
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 1/5
49/100 composite
Fundamentals58
Regulatory58
Market40
Editorial30
Composite · trailing 12 months

The model outputs a Neutral rating for Rubicon Organics, scoring 49/100 at conviction 1 of 5. Weights are locked at 35 percent fundamentals, 25 percent regulatory, 25 percent market, and 15 percent editorial, and each pillar is broken out for direct review. The regulatory pillar contributes the largest share at 58, steadying the composite into the middle of the band. Opposite that, editorial prints only 30, and is what keeps the rating anchored where it is.

Pillar-level, the record reads as reported revenue growth of 10.6 percent year over year, an operating margin of -18.5 percent. Each of those data points tethers the Neutral conclusion to observable evidence. Inputs are limited to primary regulatory filings, licensed fundamentals data, and institutional pricing feeds, plus a density read from CIN newsroom coverage. The rating enables direct comparison across the 336 tickers in the CIN coverage universe on a consistent, deterministic basis, and refreshes on a scheduled cadence tied to the primary-source ingest cycle.

Watch the regulatory pillar, which drives 58 of the composite. Continued filing cadence at or above the trailing 90-day pace, matched with a clean enforcement record, would justify moving toward the upper band edge.

Scored: 2026-07-14Valid through: 2026-08-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Headquarters
505-744 WEST HASTINGS STREET, VANCOUVER, A1, V6C 1A5
Phone
604-849-3733
CEO
Margaret Brodie
CFO
Glen Ibbott
SEC CIK
1742195
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$21.0M
Enterprise value
$28.6M
Price to book
0.70
Price to sales
0.35
EV / EBITDA
13.03
Revenue (TTM)
$60.8M
Gross profit (TTM)
$21.4M
EBITDA
$2.6M
Operating margin
-18.5%
Profit margin
-2.3%
Rev growth YoY
10.6%
Return on equity
-3.5%
Return on assets
-0.6%
EPS (TTM)
$-0.01
Shares outstanding
67.6M
Insider ownership
42.5%
Institutional ownership
3.3%
Beta
0.39
Full-time employees
263
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Filing portal
SEDAR+
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Rubicon Organics (ROMJF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Rubicon Organics (ROMJF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Bullish and bearish analyst opinions for Rubicon Organics Inc. (ROMJF)

Bullish view. Rubicon Organics Inc. runs a certified-organic Canadian premium flower operation and has posted rare positive gross-margin quarters versus a sea of loss-making LP peers.

Bearish view. Bears note the small revenue base, Canadian rec price pressure, and limited runway for further margin expansion at scale.

Live ratings, price targets, and consensus figures for Rubicon Organics Inc. appear above this summary. Explore analyst coverage across the 326-equity cannabis universe.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for ROMJF are maintained by Cannabis Investor News and refreshed throughout the trading day.